Agilera has a robust network, which enables preclinical innovation. Our preclinical lab facilities have been approved as a type B isotope laboratory, and are located in close proximity to our GMP production plant.
Agilera has experience with small molecules, peptides and antibodies, as well as expertise in chelation chemistry, formulation and product development, both for manual and automated processes.
We offer the tech transfer of production processes from the early phase of a development cycle to the commercial phase.